Welcome to LookChem.com Sign In|Join Free
  • or
N-(m-aminophenyl)aniline, a member of the m-phenylenediamines class, is an organic compound characterized by a benzene ring with two nitrogen atoms. One nitrogen is part of an amine group (-NH2), and the other is part of an aniline group, a derivative of ammonia. Its role in industry is not well-defined, but it can serve as a precursor in chemical reactions. The safety, toxicity, and environmental impact of N-(m-aminophenyl)aniline have not been extensively studied.

5840-03-9

Post Buying Request

5840-03-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5840-03-9 Usage

Uses

Used in Chemical Synthesis:
N-(m-aminophenyl)aniline is used as a precursor in chemical synthesis for [application reason], contributing to the formation of various compounds and materials. Its role in this process is to facilitate the creation of new substances through its reactive nitrogen atoms.
Used in Pharmaceutical Industry:
N-(m-aminophenyl)aniline is used as an intermediate in the pharmaceutical industry for [application reason], potentially aiding in the development of new drugs and therapeutic agents. Its chemical structure allows for further modification and functionalization, which can be crucial in drug design.
Used in Dye and Pigment Industry:
N-(m-aminophenyl)aniline is used as a building block in the dye and pigment industry for [application reason], such as creating new colors or improving the properties of existing dyes and pigments. Its aromatic structure and nitrogen-containing groups can contribute to the color intensity and stability of these products.
Used in Research and Development:
N-(m-aminophenyl)aniline is used as a research compound in academic and industrial R&D for [application reason], such as studying its reactivity, exploring its potential applications, or investigating its interactions with other molecules. This can lead to a better understanding of its properties and possible uses in various fields.

Check Digit Verification of cas no

The CAS Registry Mumber 5840-03-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,8,4 and 0 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 5840-03:
(6*5)+(5*8)+(4*4)+(3*0)+(2*0)+(1*3)=89
89 % 10 = 9
So 5840-03-9 is a valid CAS Registry Number.
InChI:InChI=1/C12H12N2/c13-10-5-4-8-12(9-10)14-11-6-2-1-3-7-11/h1-9,14H,13H2

5840-03-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name N-Phenyl-benzene-1,3-diamine

1.2 Other means of identification

Product number -
Other names 3-N-phenylbenzene-1,3-diamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5840-03-9 SDS

5840-03-9Relevant academic research and scientific papers

Growing the molecular architecture of imidazole-like ligands in HO-1 complexes

Floresta, Giuseppe,Fallica, Antonino N.,Salerno, Loredana,Sorrenti, Valeria,Pittalà, Valeria,Rescifina, Antonio

, (2021/10/29)

Up-regulation of HO-1 had been frequently reported in different cases and types of human malignancies. Since poor clinical outcomes are reported in these cases, this enzyme's inhibition is considered a valuable and proven anticancer approach. To identify

HETEROCYCLIC COMPOUNDS FOR MODULATING NR2F6

-

Paragraph 00503-00504; 00527, (2021/09/04)

The present disclosure relates to compounds capable of modulating the activity of NR2F6. The compounds of the disclosure may be used in methods for the prevention and/or the treatment of diseases and disorders associated with modulating NR2F6 activity.

PSNCBAM-1 analogs: Structural evolutions and allosteric properties at cannabinoid CB1 receptor

Meini, Serena,Gado, Francesca,Stevenson, Lesley A.,Digiacomo, Maria,Saba, Alessandro,Codini, Simone,Macchia, Marco,Pertwee, Roger G.,Bertini, Simone,Manera, Clementina

, (2020/07/20)

Allosteric modulation of the CB1Rs could represent an alternative strategy for the treatment of diseases in which these receptors are involved, without the undesirable effects associated with their orthosteric stimulation. PSNCBAM-1 is a reference diaryl urea derivative that positively affects the binding affinity of orthosteric ligands (PAM) and negatively affects the functional activity of orthosteric ligands (NAM) at CB1Rs. In this work we reported the design, synthesis and biological evaluation of three different series of compounds, derived from structural modifications of PSNCBAM-1 and its analogs reported in the recent literature. Almost all the new compounds increased the percentage of binding affinity of CP55940 at CB1Rs, showing a PAM profile. When tested alone in the [35S]GTPγS functional assay, only a few derivatives lacked detectable activity, so were tested in the same functional assay in the presence of CP55940. Among these, compounds 11 and 18 proved to be functional NAMs at CB1Rs, dampening the orthosteric agonist-induced receptor functionality by approximately 30percent. The structural features presented in this work provide new CB1R-allosteric modulators (with a profile similar to the reference compound PSNCBAM-1) and an extension of the structure-activity relationships for this type of molecule at CB1Rs.

One-pot propagation of (Hetero)Arylamines: Modular synthesis of diverse Amino-di(hetero)arylamines

Liang, Xueting,Xu, Liang,Li, Cuihua,Jia, Xin,Wei, Yu

, p. 721 - 731 (2019/01/08)

Formal propagation of (hetero)arylamine is achieved via a one-pot Buchwald–Hartwig C–N cross-coupling and nitro reduction sequence, enabling a rapid modular synthesis of diverse amino-di(hetero)arylamines from (hetero)arylamines and halogenated nitrobenzenes. Various functionalized aromatic amines with different electronic and steric environments can be efficiently prolongated to formally incorporate another arylamino fragments. This approach has been successfully applied in the synthesis of more than forty amino-di(hetero)arylamines. The applicability of this method has also been demonstrated in the synthesis of oligoanilines and the tyrosine-kinase inhibitor Imatinib.

Discovery of 2-((4,6-dimethylpyrimidin-2-yl)thio)-N-phenylacetamide derivatives as new potent and selective human sirtuin 2 inhibitors

Yang, Lingling,Ma, Xiaobo,Yuan, Chen,He, Yanying,Li, Ling,Fang, Sha,Xia, Wei,He, Tao,Qian, Shan,Xu, Zhihong,Li, Guobo,Wang, Zhouyu

supporting information, p. 230 - 241 (2017/04/19)

Human sirtuin 2 (SIRT2) plays pivotal roles in multiple biological processes such as cell cycle regulation, autophagy, immune and inflammatory responses. Dysregulation of SIRT2 was considered as a main aspect contributing to several human diseases, including cancer. Development of new potent and selective SIRT2 inhibitors is currently desirable, which may provide a new strategy for treatment of related diseases. Herein, a structure-based optimization approach led to new 2-((4,6-dimethylpyrimidin-2-yl)thio)-N-phenylacetamide derivatives as SIRT2 inhibitors. SAR analyses with new synthesized derivatives revealed a number of new potent SIRT2 inhibitors, among which 28e is the most potent inhibitor with an IC50 value of 42?nM. The selectivity analyses found that 28e has a very good selectivity to SIRT2 over SIRT1 and SIRT3. In cellular assays, 28e showed a potent ability to inhibit human breast cancer cell line MCF-7 and increase the acetylation of α-tubulin in a dose-dependent manner. This study will aid further efforts to develop highly potent and selective SIRT2 inhibitors for the treatment of cancer and other related diseases.

Novel SIRT2 protein inhibitor and usage thereof in pharmacy

-

Paragraph 0091; 0093, (2017/08/28)

The invention discloses a compound or salt, crystallographic form and solvate compounds of the compound acceptable in pharmacy, and the compound and the salt, crystallographic form, solvate compounds of the compound are shown as formula I, wherein X is selected from the formulas (please see the specifications for the formula); R1 is selected from aryl or ceteroary or substituted aryl or substituted ceteroary or from the formula (please see the specifications for the formula); R2 is selected from the formulas (please see the specifications for the formula); and R3 is selected from halogen or C1-C4 alkyl or C1-C4 alkoxy. The novel compound shown in formula I has the advantages that not only is good inhibitory activity achieved to SIRT2, but also the inhibiting effect is achieved to the tumor, and the novel compound has good pharmaceutical potentiality and provides a novel potential choice for the clinical medicament.

Nickel(0)/N-heterocyclic carbene complexes catalysed arylation of aromatic diamines

Kuhl, Sébastien,Fort, Yves,Schneider, Rapha?l

, p. 6169 - 6177 (2007/10/03)

Nickel complexes of N-heterocyclic carbenes were examined for effecting C-N coupling reactions between aromatic diamines and aryl chlorides of varying electron density. The Ni(0) ? 2IPr (IPr = N,N′-bis(2,6- diisopropylphenyl)imidazol-2-ylidene) complex associated to t-BuONa allowed N,N′-diarylation at 100 °C in 1,4-dioxane with excellent yields. Selective monoarylation of diamines could be performed in THF at 65 °C.

On attempted oxidative cyclisation of isomeric N,N'-diphenylphenylenediamines and their N,N'-dimethyl derivatives by palladium(II) acetate and UV light

Chakrabarty,Batabyal,Khasnobis

, p. 3651 - 3668 (2007/10/03)

The cyclisation of N,N'-diphenyl-o-, m- and p-phenylenediamines and their N,N'-dimethyl derivatives by palladium(II) acetate and UV light separately led to both bis-cyclisation, furnishing indolocarbazoles, and mono-cyclisations with cleavage as well as retention of one substituent, producing substituted carbazoles.

Preparation and pharmacological activities of 10-homolupinanoyl-2-R- phenothiazines

Sparatore,Sparatore

, p. 5 - 17 (2007/10/02)

Pursuing our researches on quinolizidinyl derivatives of phenothiazine and on the ground of antidepressive, diuretic, antianginal and antiarrhythmic activities of several 10-(3-dialkylamino) propionylphenothiazines (as chloracizine, moricizine, etc.), six

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5840-03-9